Cargando…

Synthesis and Characterization of Process-Related Impurities of Antidiabetic Drug Linagliptin

Linagliptin, a xanthine derivative, is a highly potent, selective, long-acting and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. During the process development of linagliptin, five new process-related impurities were detected by high performance liquid chromatography (HPL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yiwen, He, Xiaoqing, Wu, Taizhi, Zhang, Fuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274017/ https://www.ncbi.nlm.nih.gov/pubmed/27517889 http://dx.doi.org/10.3390/molecules21081041

Ejemplares similares

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug
por: Dams, Iwona, et al.
Publicado: (2017)

Biological Safety Studies and Simultaneous Determination of Linagliptin and Synthetic Impurities by LC-PDA
por: Heleno Ferreira, Raquel Balestri, et al.
Publicado: (2019)

Synthesis and Characterization of Impurities in the Production Process of Lopinavir
por: Raghava Reddy, Ambati V., et al.
Publicado: (2015)

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds
por: Gao, Shenghua, et al.
Publicado: (2018)

Identification, synthesis and characterization of avanafil process impurities and determination by UPLC
por: Zhao, Mengmeng, et al.
Publicado: (2022)

Separation and Characterization of Novel Degradation and Process Related Impurities of Bedaquiline Bulk Drug
por: Vanavi, Pragati J, et al.
Publicado: (2021)

Identification, synthesis and characterization of process related desfluoro impurity of ezetimibe and HPLC method validations()
por: Bellur Atici, Esen, et al.
Publicado: (2015)

Synthesis and Characterization of Impurities of Barnidipine Hydrochloride, an Antihypertensive Drug Substance
por: Cheng, Zhi-Gang, et al.
Publicado: (2014)

Synthesis and Physicochemical Characterization of the Impurities of Pemetrexed Disodium, an Anticancer Drug
por: Michalak, Olga, et al.
Publicado: (2015)

Identification and Characterization of Process-Related Impurities of Trans-Resveratrol
por: Sivakumar, Balasubramanian, et al.
Publicado: (2013)

Development of RP-HPLC, Stability Indicating Method for Degradation Products of Linagliptin in Presence of Metformin HCl by Applying 2 Level Factorial Design; and Identification of Impurity-VII, VIII and IX and Synthesis of Impurity-VII
por: Jadhav, Sushant B., et al.
Publicado: (2017)

Synthesis, Characterization and Quantification of Simvastatin Metabolites and Impurities
por: Bhatia, Manish S., et al.
Publicado: (2011)

Identification, Synthesis, and Characterization of Novel Baricitinib Impurities
por: Vaddamanu, Guruswamy, et al.
Publicado: (2023)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

DSC, FT-IR and NIR with Chemometric Assessment Using PCA and HCA for Estimation of the Chemical Stability of Oral Antidiabetic Drug Linagliptin in the Presence of Pharmaceutical Excipients
por: Gumieniczek, Anna, et al.
Publicado: (2022)

Isolation and Characterization of a Process Impurity in Tizanidine Hydrochloride
por: Vijayakumar, E. K. S., et al.
Publicado: (2010)

Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR
por: Kumar, Neeraj, et al.
Publicado: (2017)

Inferior and Impure Drugs
Publicado: (1872)

Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations()
por: Bellur Atici, Esen, et al.
Publicado: (2015)

Linagliptin: A thorough Characterization beyond Its Clinical Efficacy
por: Sortino, Maria Angela, et al.
Publicado: (2013)

Identification and Physicochemical Characteristics of Temozolomide Process-Related Impurities
por: Łaszcz, Marta, et al.
Publicado: (2013)

Synthesis of RP 48497, an Impurity of Eszopiclone
por: Sha, Yu, et al.
Publicado: (2008)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Solriamfetol impurities: Synthesis, characterization, and analytical method (UPLC-UV) validation
por: Al-Rifai, Nafisah, et al.
Publicado: (2023)

Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method
por: Xu, Ao, et al.
Publicado: (2023)

Synthesis of Isomeric and Potent Impurities of the Triazole-Based Antifungal Drug Voriconazole
por: Sundaram, Dhanraj T. S. S., et al.
Publicado: (2015)

Analysis and characterization of heparin impurities
por: Beni, Szabolcs, et al.
Publicado: (2010)

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine
por: Ott, Christian, et al.
Publicado: (2021)

Impurity profiling and in-process testing of drugs for injection by fast liquid chromatography
por: Rocheleau, Marie-Josée, et al.
Publicado: (2012)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
por: Kang, Woo Youl, et al.
Publicado: (2020)

The neuroprotective effects of the anti-diabetic drug linagliptin against Aβ-induced neurotoxicity
por: Lin, Chih-Li, et al.
Publicado: (2016)

Synthesis and Characterization of Organic Impurities in Bortezomib Anhydride Produced by a Convergent Technology
por: Ivanov, Andrey S., et al.
Publicado: (2012)

Identification, Synthesis, and Characterization of Potential Oxidative Impurities of Venetoclax: Application of Meisenheimer Rearrangement
por: Vaddamanu, Guruswamy, et al.
Publicado: (2023)

Acute Kidney Injury Associated with Linagliptin
por: Nandikanti, Deepak K., et al.
Publicado: (2016)

Incorrect description of mode of excretion of linagliptin
por: Woerle, Hans-Juergen, et al.
Publicado: (2010)

Linagliptin-Associated Alopecia and Bullous Pemphigoid
por: Someili, Ali, et al.
Publicado: (2019)

Analytical Enantio-Separation of Linagliptin in Linagliptin and Metformin HCl Dosage Forms by Applying Two-Level Factorial Design
por: Jadhav, Sushant B., et al.
Publicado: (2016)

Continuous-Flow Synthesis of Nitro-o-xylenes: Process Optimization, Impurity Study and Extension to Analogues
por: Song, Qiao, et al.
Publicado: (2022)

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?
por: Dams, Iwona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8sla0f9foo2j5ajjkur7jhntij